Thrombosis Caused by Factor XI Gly397Ser Mutation with Enhanced Procoagulant Activity
Thrombosis and Haemostasis · 08.12.2025
DOI: 10.1055/a-2740-1731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 08.12.2025. Verfasst von Yanyan Shao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Shanghai Sailing Program, The Youth Program of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Elevated FXI levels are associated with increased risk of venous thromboembolism, yet genetic mutations contributing to elevated FXI levels have not been reported yet. We described a patient with a history of deep venous thrombosis (DVT) who tested negative on routine laboratory screening but was found to carry a novel pathogenic FXI mutation, Gly397Ser (G397S). FXI mutant protein was expressed, and functional assays were conducted in vitro to explore the underlying thrombotic mechanism. Consistent with FXI activity (FXI:C) and antigen (FXI:Ag) determined in the patient, the FXI G397S mutant exhibited a 2-fold increase of FXI:C/FXI:Ag. FXIa hydrolysis assay demonstrated that the Km value for G397S mutant was comparable to the wild-type FXIa (186.2~281.9 μM V.S. 141.6~242.6 μM), whereas the mutant FXIa displayed approximately 3-fold increases in kcat values. FXI activation by polyanions was more pronounced in the G397S mutant. Notably, this activation was more significant when triggered by thrombin compared with FXIIa in the presence of heparin. Otherwise, the G397S FXI mutant exhibited similar hydrolytic activity of FXIa against FIX, and equivalent inhibition of FXIa by Protease nexin 2 (PN2). Clot lysis assay revealed that the lysis time was longer in G397S mutant than the wild-type and the enhanced fibrinolytic resistance was thrombin-activatable fibrinolysis inhibitor-dependent. In summary, the FXI G397S mutation exhibited higher FXIa activity mainly because of the enhanced activation of FXI, which sustained thrombin generation and manifested resistance to fibrinolysis, ultimately leading to the development of DVT.
Autor:innen und Institutionen
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine…
- State Key Laboratory of Microbial Metabolism and Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
- Chemistry and Material Science Faculty, Shandong Agricultural University, Taian, China.
- Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Faculty of Laboratory Medicine, Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Förderung
- Shanghai Sailing Program
- The Youth Program of the National Natural Science Foundation of China
Zitieren
APA
Shao, Y., Xu, Y., Xin, M., Xu, Q., Chen, W., Ren, W., Liang, Q., Li, L., Wu, X., Liu, Y., Xu, G., Lou, C., Ding, Q., Wu, W., Wang, X., & Dai, J. (2025). Thrombosis Caused by Factor XI Gly397Ser Mutation with Enhanced Procoagulant Activity. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2740-1731
Vancouver
Shao Y, Xu Y, Xin M, Xu Q, Chen W, Ren W, et al. Thrombosis Caused by Factor XI Gly397Ser Mutation with Enhanced Procoagulant Activity. Thrombosis and Haemostasis. 2025. doi:10.1055/a-2740-1731
BibTeX
@article{Shao2025,
author = {Shao, Yanyan and Xu, Yang and Xin, Min and Xu, Qin and Chen, Weizhi and Ren, Wansheng and Liang, Qian and Li, Lei and Wu, Xi and Liu, Yu and Xu, Guanqun and Lou, Can and Ding, Qiulan and Wu, Wenman and Wang, Xuefeng and Dai, Jing},
title = {Thrombosis Caused by Factor XI Gly397Ser Mutation with Enhanced Procoagulant Activity},
journal = {Thrombosis and Haemostasis},
year = {2025},
doi = {10.1055/a-2740-1731}
}
EUVIMED